Wednesday, Acelyrin Inc SLRN released proof-of-concept data from an ongoing Phase 1/2 trial of lonigutamab in thyroid eye disease (TED). Lonigutamab is a…
JERUSALEM, March 20, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. ENTX, (“Entera” or the “Company”) a leader in the development…
Friday, Merck & Co Inc MRK announced that the Phase 3 KEYNOTE-A18 trial, also known as ENGOT-cx11/GOG-3047, of Keytruda (pembrolizumab) in combination…
Washington lawmakers recently approved a bill that would eliminate excise taxes on medical marijuana products, reported Forbes. First introduced last year, HB 1453,…
Tuesday, Pfizer Inc PFE announced that a Phase 3 study of the antibody-drug conjugate Adcetris (brentuximab vedotin) combined with lenalidomide and rituximab…
An aging U.S. population with increasingly complex medical diagnoses has doctors and clinicians under pressure to diagnose and treat patients…
CASI Pharmaceuticals Inc CASI and BioInvent International AB announced preliminary efficacy data for BI-1206 in combination with rituximab in patients with relapsed/refractory (R/R)…
The second most populated country in Europe, Germany, legalized recently marijuana. What does this mean? Even though Germany’s cannabis legalization…
PALO ALTO, CALIFORNIA – February 26, 2024 (GLOBE NEWSWIRE) – Scilex Holding Company SCLX (“Scilex” or “Company”), an innovative revenue-generating…
South Dakota’s House of Representatives approved a measure Thursday requiring the names of registered medical marijuana patients to be added to…